Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia
Open Access
- 16 March 2015
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 29 (10), 2104-2107
- https://doi.org/10.1038/leu.2015.76
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene ScoreJournal of Clinical Oncology, 2014
- Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid LeukemiaJournal of Clinical Oncology, 2013
- High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A StudyJournal of Clinical Oncology, 2013
- Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: miR-155 Upregulation Independently Identifies High-Risk PatientsJournal of Clinical Oncology, 2013
- Acute myeloid leukaemia in adultsThe Lancet, 2013
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaNew England Journal of Medicine, 2012
- Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment AssignmentJournal of Clinical Oncology, 2011
- Anthracycline Dose Intensification in Acute Myeloid LeukemiaNew England Journal of Medicine, 2009
- Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS studyLeukemia, 2008
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003